Literature DB >> 19542615

Neuropathology-based risk scoring for dementia diagnosis in the elderly.

Sebastien Haneuse1, Eric Larson, Rod Walker, Thomas Montine, Joshua Sonnen.   

Abstract

Current neuropathologic consensus criteria for diagnosis of dementia yield a classification of processes that likely contributed to dementia in that individual. While dementia diagnosis currently relies on clinical criteria, practicing neuropathologists and researchers might benefit from a simple, accurate risk scoring protocol for the neuropathologic diagnosis of dementia. Using 232 consecutive autopsies from the population-based Adult Changes in Thought study, we developed two logistic regression-based risk scoring systems; one solely using neuropathologic measures and a second additionally including demographic information. Inverse-probability weighting was used to adjust for inherent selection bias in autopsy-based studies of dementing illnesses. Both systems displayed high levels of predictive accuracy; bias-adjusted area-under-the-curve statistics were 0.78 (95% CI 0.71, 0.85) and 0.87 (95% CI 0.83, 0.92), indicating improved performance with the inclusion of demographic characteristics, specifically age and birth cohort information. Application of the combined neuropathology/demographic model yielded bias-adjusted sensitivity and specificity of 81% each. In contrast, application of NIA-Reagan criteria yielded sensitivity and specificity of 53% and 84%. Our proposed scoring systems provide neuropathologists with tools to make a diagnosis, and interpret their diagnosis in the light of known sensitivity and specificity estimates. Evaluation in independent samples will be important to verify our findings.

Entities:  

Mesh:

Year:  2009        PMID: 19542615      PMCID: PMC2852462          DOI: 10.3233/JAD-2009-1105

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

1.  University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988.

Authors:  E B Larson; W A Kukull; L Teri; W McCormick; M Pfanschmidt; G van Belle; M Sumi
Journal:  Aging (Milano)       Date:  1990-12

2.  Simplified neuropathological diagnosis of dementia with Lewy bodies.

Authors:  A J Harding; G M Halliday
Journal:  Neuropathol Appl Neurobiol       Date:  1998-06       Impact factor: 8.090

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

Authors:  R Mayeux; A M Saunders; S Shea; S Mirra; D Evans; A D Roses; B T Hyman; B Crain; M X Tang; C H Phelps
Journal:  N Engl J Med       Date:  1998-02-19       Impact factor: 91.245

5.  Alzheimer neuropathologic alterations in aged cognitively normal subjects.

Authors:  D G Davis; F A Schmitt; D R Wekstein; W R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

Review 6.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

7.  Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease.

Authors:  J W Geddes; T L Tekirian; N S Soultanian; J W Ashford; D G Davis; W R Markesbery
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 8.  Subcortical ischaemic vascular dementia.

Authors:  Gustavo C Román; Timo Erkinjuntti; Anders Wallin; Leonardo Pantoni; Helena C Chui
Journal:  Lancet Neurol       Date:  2002-11       Impact factor: 44.182

9.  Neuropathology of cognitively normal elderly.

Authors:  D S Knopman; J E Parisi; A Salviati; M Floriach-Robert; B F Boeve; R J Ivnik; G E Smith; D W Dickson; K A Johnson; L E Petersen; W C McDonald; H Braak; R C Petersen
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

10.  The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia.

Authors:  E L Teng; K Hasegawa; A Homma; Y Imai; E Larson; A Graves; K Sugimoto; T Yamaguchi; H Sasaki; D Chiu
Journal:  Int Psychogeriatr       Date:  1994       Impact factor: 3.878

View more
  9 in total

1.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

2.  Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.

Authors:  Cyntia Tremblay; Isabelle St-Amour; Julie Schneider; David A Bennett; Frédéric Calon
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

Review 3.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

Review 4.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

5.  A History of Senile Plaques: From Alzheimer to Amyloid Imaging.

Authors:  Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2022-05-20       Impact factor: 3.148

6.  Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.

Authors:  Alberto Serrano-Pozo; Jing Qian; Sarah E Monsell; Matthew P Frosch; Rebecca A Betensky; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2013-12       Impact factor: 3.685

7.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.

Authors:  Michael M Witte; Norman L Foster; Adam S Fleisher; Monique M Williams; Kimberly Quaid; Michael Wasserman; Gail Hunt; J Scott Roberts; Gil D Rabinovici; James L Levenson; Ann Marie Hake; Craig A Hunter; Luann E Van Campen; Michael J Pontecorvo; Helen M Hochstetler; Linda B Tabas; Paula T Trzepacz
Journal:  Alzheimers Dement (Amst)       Date:  2015-07-26

Review 9.  Methods to Address Self-Selection and Reverse Causation in Studies of Neighborhood Environments and Brain Health.

Authors:  Lilah M Besser; Willa D Brenowitz; Oanh L Meyer; Serena Hoermann; John Renne
Journal:  Int J Environ Res Public Health       Date:  2021-06-16       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.